(lp0
S'Oramed Pharmaceuticals Inc. MarketWatch - Apr 21, 2011 Oramed Pharmaceuticals Inc. NASDAQ: ORMP. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p1
aS'Oramed Pharmaceuticals Inc. ORMP  Wall Street Journal - Feb 11, 2013 Oramed Pharmaceuticals Inc. ORMP . search. View All companies. AT CLOSE 3:38 PM EST 03/10/17. $6.03 USD; 0.01 0.17%.'
p2
aS'Sell-side Target Update on Oramed Pharmaceuticals Inc.  Aiken Advocate - 9 hours ago Sell-side equity research analysts have handed shares of Oramed Pharmaceuticals Inc.  a short term price target of $25.'
p3
aS'Does Oramed Pharmaceuticals Pass The Smell Test? Seeking Alpha - May 23, 2014 First off, thank you to the M.D. and Pharma classmates who helped to explain the intricacies of the clinical trial and drug patent process.'
p4
aS'Oramed: The Atypical Biotechnology Company With Great Upside Potential Seeking Alpha - Jul 1, 2016 Oramed , the biotech company involved in the research and development of orally deliverable insulin, is a great investment opportunity for investors that are looking for a growing small stock in the biotechnology industry.'
p5
aS'ORAMED PHARMACEUTICALS INC.  Files An 8-K Other Events Market Exclusive - Mar 21, 2017 Oramed Pharmaceuticals Inc.  is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection.Oramed Appoints Dr. Ronald Law as Chief Strategy Officer - Yahoo FinanceOramed Pharma  Appoints Dr. Ronald Law as CSO - StreetInsider.com'
p6
aS"Oramed Pharmaceuticals'  CEO Nadav Kidron Hosts Phase IIb Clinical ... Seeking Alpha - Jul 29, 2016 I encourage you to review the cautionary language about forward-looking statements in today's press release, which can be found on Oramed's website, as well as the Company's filings with the Securities and Exchange Commission including, without&nbsp;..."
p7
aS"Here's Where Oramed Fits Into The Diabetes Space Seeking Alpha - Feb 17, 2017 One company that is attempting to do exactly that right now, and that looks to have an attractive pitch, is Oramed Pharmaceuticals Inc. . The company's CEO, Nadav Kidron, featured on CNBC's Squawk Box earlier this week and highlighted&nbsp;..."
p8
aS"Oramed Vs. Novo Nordisk In Race For Oral GLP-1 Seeking Alpha - Nov 29, 2016 As diabetes drug frontrunners scramble to create the next best thing, GLP-1, a powerful hormone designed to tell the pancreas when to release insulin, brings face-to-face two strong contenders for an oral version: Oramed Pharmaceuticals Inc.Oramed's ORMD-0901  Found Safe and Well Tolerated in Phase ... - PR Newswire "
p9
aS'Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50000000 ... PR Newswire  - Jul 7, 2015 Oramed Pharmaceuticals Inc.  , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has signed a non-binding Letter of Intent  for an&nbsp;...'
p10
a.